| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/20/2005 | EP1555024A1 Antibacterial medicinal composition of enhanced oral absorptivity |
| 07/20/2005 | EP1554586A2 Screening method |
| 07/20/2005 | EP1554306A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 07/20/2005 | EP1554301A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 07/20/2005 | EP1554276A1 Non-nucleoside reverse transcriptase inhibitors |
| 07/20/2005 | EP1554274A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 07/20/2005 | EP1554273A1 Antimicrobial 1-aryl dihydropyridone compounds |
| 07/20/2005 | EP1554261A1 Antibacterial agents |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553981A1 Bacterial transforming agent |
| 07/20/2005 | EP1553977A2 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553954A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/20/2005 | EP1553940A1 Parenteral formulations containing a rapamycin hydroxyester |
| 07/20/2005 | EP1553935A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 07/20/2005 | EP1553920A1 Topical formulation for prevention and treatment of acne |
| 07/20/2005 | EP1553831A2 Process for screening fungitoxic compounds |
| 07/20/2005 | EP1324736A4 Rapid antibiotic susceptibility test |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1259629B1 Recombinant influenza a viruses |
| 07/20/2005 | EP1231929B1 Antiviral composition comprising a palmaria palmata extract |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1146867B1 Antibacterial hydroxamic acid derivatives |
| 07/20/2005 | EP1001759B1 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 07/20/2005 | EP0869814B1 Stabilisers for live vaccines |
| 07/20/2005 | EP0861085B1 Anti-viral isolates obtained from leeches |
| 07/20/2005 | EP0784430B1 Method for reducing unwanted cellular adhesions |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643139A Bacteriophages |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642974A Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) |
| 07/20/2005 | CN1642966A Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| 07/20/2005 | CN1642956A Dipyridodiazepinones as reverse transcriptase inhibitors |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642954A Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |
| 07/20/2005 | CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642890A Benzyl alcohol derivatives |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642571A Virus-like particles of human papillomavirus |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642564A Composition containing moutan root bark extract as active ingredient |
| 07/20/2005 | CN1642563A Compositions and methods for treatment of skin disorders |
| 07/20/2005 | CN1642561A Compositions containing labile bioactive materials, methods of preparation and treatment |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642543A Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| 07/20/2005 | CN1642540A Suramin and derivatives thereof as topical microbicide and contraceptive |
| 07/20/2005 | CN1642535A Tuberculosis treatment using pleuromutilin derivatives |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1642437A Probiotic delivery system |
| 07/20/2005 | CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 07/20/2005 | CN1641033A Novel marneffei penicillium TIM9 protein and its coding sequence |
| 07/20/2005 | CN1641032A Novel marneffei penicillium ERG25 Gene and its coding protein |
| 07/20/2005 | CN1641031A Novel marneffei penicillium TIM17 protein and its coding sequence |
| 07/20/2005 | CN1640879A One-step method for preparing high-purity cefpoxime proxetil |
| 07/20/2005 | CN1640497A Swing breeding and respiratory syndrome suicide DNA vaccine and use |
| 07/20/2005 | CN1640494A Method for preparing avian polyvalent nucleic acid vaccine containing multiple virus antigen epitope |
| 07/20/2005 | CN1640486A Anti-chickenpest ball |
| 07/20/2005 | CN1640477A Method for preparing aerosol for preventing flu |
| 07/20/2005 | CN1640468A Chinese medicine for treating SARS |
| 07/20/2005 | CN1640457A Chinese medicine composition for treating viral hepatitis B |
| 07/20/2005 | CN1640450A Medicine for treating tuberculous lymphadenitis |
| 07/20/2005 | CN1640448A Stagnated hepatoqi dispersing medicine for preventing and treating SARS and viral hepatitis complication |
| 07/20/2005 | CN1640447A Method for preparing medicine for treating viral carditis and its use |
| 07/20/2005 | CN1640422A Medicine for treating AIDS |
| 07/20/2005 | CN1640408A Multifunctional anti virus lozenge |
| 07/20/2005 | CN1640404A Ganciclovir injection liquid and its production method |
| 07/20/2005 | CN1640397A Kurarinol drop pill and its preparing method |
| 07/20/2005 | CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640390A Novel sodium houttuynin lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640389A Medicine for treating bacterial vaginitis and its preparing method |
| 07/20/2005 | CN1211488C Modified plant viruses as vectors of heterologous peptides |
| 07/20/2005 | CN1211487C Mutants of streptococcal toxin A and methods of use |
| 07/20/2005 | CN1211391C Crystal form of pifuadefuwei |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211384C Thiadiazolyl and oxidiazolyl phenyl oxazolidinone antibacterial agent |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/20/2005 | CN1211335C Compounds for the suppression of HIV TAT transactivation |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |